Daniel Char

General Counsel, Evelo Biosciences, Inc.

Companies

Quanterix (United States)General counsel Mar 24, 2026 to now¹
ImmunoGen Inc.General counsel Nov 30, 2022 to Feb 12, 2024²
Evelo Biosciences, Inc.General counsel Nov 1, 2018 to Oct 14, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ImmunoGen Inc. IMGN0 shares⁴Feb 12, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 12, 2024Returned to company 1,000 shares of ImmunoGen Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARQuanterix (United States), General counsel
2
SEC EDGARImmunoGen Inc., General counsel
3
SEC EDGAREvelo Biosciences, Inc., General counsel
4
SEC EDGARImmunoGen Inc. shares after the filing of Feb 12, 2024